Science Daily -
3 Jun 2014 22:21
An examination of the benefit of preventive placement of implantable cardioverter-defibrillators in patients with a less severe level of heart failure, a group not well represented in clinical trials, finds significantly better survival at three years than that of similar patients with no ICD, according to a study.
Share this Article
Comment on this Article
Please to comment